A low-profile biotech out to shake up how the industry imagines antibody therapeutics is attracting some eyeballs today with a $103 million megaround.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,